Corpus overview


Overview

MeSH Disease

Human Phenotype

Transmission

Seroprevalence
    displaying 1 - 2 records in total 2
    records per page




    Acute Pulmonary Embolism HP Pulmonary Embolism MESHD In Non-Hospitalized Covid-19 Patients Referred To CTPA By Emergency Department

    Authors: GERVAISE Alban; BOUZAD Caroline; PEROUX Evelyne; HELISSEY Carole

    doi:10.21203/rs.3.rs-26229/v1 Date: 2020-04-29 Source: ResearchSquare

    Objectives: To evaluate the prevalence SERO of acute pulmonary embolism HP pulmonary embolism MESHD (APE) in non-hospitalized COVID-19 patients referred to CT pulmonary angiography (CTPA) by Emergency Department.Methods: From March 14 to April 6, 2020, 72 non-hospitalized patients referred by Emergency Department to CTPA for COVID-19 pneumonia HP pneumonia MESHD were retrospectively identified. Relevant clinical and laboratory data and CT scan findings were collected for each patient. CTPA scans were reviewed by two radiologists to determinate the presence or absence of APE MESHD. Clinical classification, lung involvement of COVID-19 pneumonia HP pneumonia MESHD and CT total severity score were compared between APE group and Non-APE group.Results: APE was identified in 13 (18%) CTPA scans. The mean age TRANS and D-dimer of patients from APE group were higher in comparison with Non-APE group (74.4 vs. 59.6 years, p=0.008 and 7.29 vs. 3.29 µg/ml, p=0.011). There was no significant difference between APE and Non-APE groups concerning clinical type, COVID-19 pneumonia HP pneumonia MESHD lung lesions (ground-glass opacity: 85 vs. 97%; consolidation: 69 vs. 68%; crazy paving: 38% vs. 37%; linear reticulation: 69 vs. 78%), CT severity score (6.3 vs. 7.1, p=0.365), quality of CTPA (1.8 vs. 2.0, p=0.518) and pleural effusion HP pleural effusion MESHD (38% vs. 19%, p=0.146).Conclusions: Non-hospitalized patients with COVID-19 pneumonia HP pneumonia MESHD referred to CT-scan by Emergency Departments are at risk of APE. Presence of APE was not limited to severe or critical clinical type of COVID-19 pneumonia HP pneumonia MESHD.

    18F-FDG PET/CT uptake in COVID-19: case report of a patient with lung metastases MESHD after treatment of nasal cavity malignancy MESHD

    Authors: Hongyan Feng; Lihong Bu

    doi:10.21203/rs.3.rs-23861/v1 Date: 2020-04-20 Source: ResearchSquare

    Background: In high COVID-19 prevalence SERO region, COVID-19 disease may be incidental found in non-specific symptoms or asymptomatic TRANS patient with history of tumor MESHD who underwent 18F-FDG-PET/CT for standard oncologic indications.Case presentation: A 51-year-old woman with a 4-year history of adenoid cystic carcinoma of nasal cavity MESHD carcinoma HP of nasal cavity underwent 18F-FDG PET/CT for restaging during COVID-19 outbreak in Wuhan. Pneumonia HP Pneumonia MESHD lesions were characterized by 18F-FDG uptake ground-glass opacities (GGOs) and multifocal high 18F-FDG-avid patchy consolidation, and without lymph node involvement and pleural effusion HP pleural effusion MESHD. Furthermore, multiple 18F-FDG-positive lung and lumbar metastases MESHD were observed. Finally, a diagnosis of COVID-19 was made based on a positive real-time fluorescent polymerase chain reaction (RT-PCR) test of SARS-CoV-2 nucleic acid. Conclusion: The non-specific symptoms or asymptomatic TRANS cancer MESHD patients presenting 18F-FDG-positive GGOs and patchy consolidation lesions in lung may favor COVID-19, who should be quickly SARS-CoV-2 nucleic acid tested and monitored.

The ZB MED preprint Viewer preVIEW includes all COVID-19 related preprints from medRxiv and bioRxiv, from ChemRxiv, from ResearchSquare, from arXiv and from Preprints.org and is updated on a daily basis (7am CET/CEST).
The web page can also be accessed via API.

Sources


Annotations

All
None
MeSH Disease
Human Phenotype
Transmission
Seroprevalence


Export subcorpus as...

This service is developed in the project nfdi4health task force covid-19 which is a part of nfdi4health.

nfdi4health is one of the funded consortia of the National Research Data Infrastructure programme of the DFG.